Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MEIC Evaluation of Acute Systemic Toxicity: Part VI. The Prediction of Human Toxicity by Rodent LD50 Values and Results From 61 In Vitro Methods.

Alternatives to laboratory animals : ATLA·2015
Same author

Influence of losartan intake on the circadian rhythm of melatonin secretion in humans.

Die Pharmazie·2014
Same author

Primary position upbeat nystagmus reversed with carbamazepine.

European journal of neurology·2011
Same author

Differential cytotoxic effects of methylmercury and organotin compounds on mature and immature neuronal cells and non-neuronal cells in vitro.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

Translocation of cadmium from cytosol to membrane fraction in cadmium-loaded red blood cells of rats.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

[Angina pectoris in patients who underwent stent implantations for severe atherosclerotic coronary lesions 16 years after heart transplantation].

Kyobu geka. The Japanese journal of thoracic surgery·2007

Related Experiment Video

Updated: Jun 29, 2026

Assessing Murine Resistance Artery Function Using Pressure Myography
07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

Association study between the variants of the human ANP gene and essential hypertension.

D Rahmutula1, T Nakayama, M Soma

  • 1Second Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.

Hypertension Research : Official Journal of the Japanese Society of Hypertension
|June 21, 2001
PubMed
Summary
This summary is machine-generated.

Genetic variants in the atrial natriuretic peptide (ANP) gene were examined for their association with essential hypertension (EH) in the Japanese population. Neither of the two studied ANP gene markers, G1837A and T2238C, showed a significant link to EH.

More Related Videos

Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta
08:08

Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta

Published on: June 10, 2015

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Related Experiment Videos

Last Updated: Jun 29, 2026

Assessing Murine Resistance Artery Function Using Pressure Myography
07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta
08:08

Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta

Published on: June 10, 2015

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Area of Science:

  • Genetics
  • Cardiovascular Disease
  • Molecular Biology

Background:

  • Atrial natriuretic peptide (ANP) gene variants are linked to hypertension and stroke risk in some populations.
  • Previous research suggests ANP variants may play a role in cardiovascular health.

Purpose of the Study:

  • To investigate the association between two specific ANP gene polymorphisms (G1837A and T2238C) and essential hypertension (EH) in the Japanese population.
  • To determine if ANP gene variants are risk factors for EH in this demographic.

Main Methods:

  • Case-control study involving 233 individuals with EH and 213 age-matched normotensive controls.
  • Genotyping of ANP gene markers G1837A and T2238C using established methods.
  • Statistical analysis to compare allele and genotype frequencies between EH and normotensive groups.

Main Results:

  • Allele frequencies for G1837A and T2238C did not significantly differ between the essential hypertension and normotensive control groups.
  • No statistically significant association was found between the G1837A or T2238C polymorphisms of the ANP gene and EH in the Japanese.
  • The studied ANP gene variants are unlikely to be markers for essential hypertension in this population.

Conclusions:

  • The G1837A and T2238C polymorphisms of the ANP gene are not associated with essential hypertension in the Japanese.
  • These findings do not support the hypothesis that these specific ANP gene variants contribute to EH pathogenesis in the Japanese population.
  • Further research may be needed to explore other genetic factors influencing EH in this demographic.